Dr. Hall serves as:
1. Division Head of Clinical and Translation Research
2. Center Director for the Clinical Pharmacy and Experimental Therapeutics Center of Excellence
3. Program director for the Dose Optimization and Outcomes Research (DOOR) progam.
The DOOR program focuses on providing evidence to optimize the dosing and outcomes of medications for obese patients. Dr. Hall was selected as a National Institutes of Health Clinical Research Scholar in 2006. He was also the recipient of the 2008 Young Alumni Award from the St. Louis College of Pharmacy.
Interests
- Cancer
- Clinical
- Critical care
- Infectious disease
- Medication
- Obesity
- Pharmacology
Pharmacy Research Interests
- antimicrobial
- antimicrobial dosing in special populations
- cancer
- clinical pharmacology
- clinical trial
- drug efficacy
- drug safety
- health outcomes
- hematology and oncology
- hematology/oncology
- infectious diseases
- obesity
- pharmacoepidemiology
- pharmacokinetic studies
- pharmacokinetics
- rural healthcare
- sepsis
- translational medicine
- vaccine